How Psychotherapy Effects The Brain

For your  FREE CONFIDENTIAL TELEPHONE CONSULTATION. call me at 972-596-1805 or 

contact me online

Psychiatric Times* (
Psychiatric Times. Vol. 28 No. 8) includes an article: "How Psychotherapy Changes the Brain: Understanding the Mechanisms."  The author is Hasse Karlsson, MA, MD, PhD.
The author note states: "Dr Karlsson is Professor of Psychiatry at the University of Helsinki and Professor of Integrative Neuroscience and Psychosomatics at the University of Turku in Finland."
Here are some excerpts:
[begin excerpts]
So far, nearly 20 studies on brain changes after psychotherapy for depression, anxiety disorders, and borderline personality disorder have been published (Table).
The first study was published nearly 20 years ago, in 1992.
In this study, the researchers compared behavior therapy with fluoxetine(Drug information on fluoxetine) treatment.
Both treatment modalities demonstrated similar changes in the brain--especially in the caudate nucleus.
Drawn together, these system level studies suggest that cognitive-behavioral therapy (CBT), dialectic behavior therapy (DBT), psychodynamic psychotherapy, and interpersonal psychotherapy alter brain function in patients suffering from major depressive disorder (MDD), obsessive-compulsive disorder, panic disorder, social anxiety disorder, specific phobias, posttraumatic stress disorder, and borderline personality disorder (BPD).3-16
The majority of these studies have reported similar brain changes after psychotherapy and medication.
However, some recent studies have also shown clear differences among these treatment modalities.
In the study by Goldapple and colleagues,5 treatment response for CBT in patients with MDD was associated with increases in metabolism in the hippocampus and dorsal cingulate and decreases in the dorsal, ventral, and medial frontal cortex.
This pattern was clearly distinct from the pattern caused by paroxetine(Drug information on paroxetine), which included increases in metabolism in the prefrontal areas and decreases in the hippocampus and subgenual cingulate.
In the recent study by Karlsson and colleagues,17 clear differences emerged between short-term psychodynamic psychotherapy and fluoxetine among patients with MDD.
From brain changes to mechanisms of psychotherapy
In addition to just reporting the findings on brain changes as a result of psychotherapy, some of these studies have made it possible to construct models that explain the mechanisms behind the changes that result from the different psychotherapies.
Many psychotherapies attempt to enhance patients' problem-solving capacities, self-representation, and regulation of affective states.
The brain areas that play a role in these functions include the dorsolateral prefrontal cortex, ventral anterior cingulate cortex, dorsal anterior cingulate cortex, ventral and dorsal subregions of the medial prefrontal cortex, posterior cingulate cortex, precuneus, insular cortex, amygdala, and ventrolateral prefrontal cortex. (For a review, see Frewen et al.18)
Because one of the major hypotheses regarding the effect of CBT on brain functioning concerns a more effective ("top-down") regulation of hyperexcitable limbic structures by prefrontal control systems, it seems that psychodynamic psychotherapy may also function, at least in part, via these mechanisms.
 The findings from a study by Beutel and colleagues10 are in line with this hypothesis and demonstrate both a frontal deactivation and an amygdala-hippocampal hyperactivation seen in symptomatic patients with panic disorder.
When their panic symptoms and anxiety levels were reduced following treatment, the frontal deactivation and amygdala-hippocampus hyperactivation were normalized.
Affective hyperarousal is the hallmark of BPD and the main target for DBT.
This would mean that DBT leads to a decrease in the activity in relation to emotional stimuli in the brain areas that serve these functions.
This was indeed found in the study by Schnell and Herpertz,15 whose findings suggest that after DBT, there is a decrease in hemodynamic response to negative stimuli in the right-sided anterior cingulate, the temporal and posterior cingulate cortices, and the left insula.
So far, only 2 Finnish studies have measured molecular level changes after psychotherapy, and in this way directly tested the hypothesis put forth by Kandel2 that psychotherapy could lead to changes in gene expression through learning, by altering the strength of synaptic connections between nerve cells and inducing morphological changes in neurons. Interestingly, in both studies, the psychotherapy that was used was psychodynamic.
In the study by Lehto and colleagues,20 19 depressive outpatients received psychodynamic psychotherapy for 12 months.
Of the patients, 8 were classified as having atypical depression.
Midbrain serotonin transporter and striatum dopamine(Drug information on dopamine) transporter densities were recorded using SPECT brain imaging with the [123I]nor--CIT radioligand before and after psychotherapy.
The researchers showed that midbrain serotonin transporter density significantly increased during psychotherapy in patients with atypical depression, but not among patients with standard depression.
There were no changes in the levels of striatum dopamine transporter.
Because of the subgroup finding, these results are difficult to interpret, and one of the shortcomings of this study is the lack of a control group.
In the other Finnish study, patients with MDD were randomized to receive either short-term psychodynamic psychotherapy or fluoxetine. Before being treated and after 4 months of treatment, they underwent a brain scan with PET using [carbonyl-11C]WAY-100635 (measures the density of serotonin type 1A [5-HT1A] receptors) and [11C]raclopride (measures density of dopamine type 2/3 receptors).
In the 2 published papers, the researchers reported that the clinical outcome in both treatment groups was similar in terms of standard symptom ratings (symptom remission was achieved in 59% of the patients and 77% of the patients met criteria for response).17,21
However, an analysis of the change in the 5-HT1A receptor density in the treatment groups revealed a significant increase in the psychotherapy group compared with the medication group, for which no change was detected (Figure).
Fluoxetine increased [11C]raclopride binding in the lateral thalamus; no change was seen in the group that received psychotherapy.
Several previous studies have found changes in 5-HT1A receptor binding in MDD that is not reversed by SSRI treatment.22-27
This could mean that the recovery process in MDD after psychotherapy is different from recovery after medication.
Currently, the clinical implications of these findings are unknown, but they may be related to the finding that suggests that the relapse rate for MDD is lower in patients treated with psychotherapy than in those treated with antidepressants.28
[end excerpts]
The article is online at: